Katz A, Udata C, Ott E et al (2009) Safety, pharmacokinetics, and pharmacodynamics of single doses of LXR-623, a novel liver X-receptor agonist, in healthy participants
Mood shifts arent a typical side effect of semaglutide, but some people have reported feeling more anxious or down while taking it
Ozempics appetite regulation led many healthcare providers to prescribe it to promote weight loss
2022 R&D Spend: In 2022, AbbVie spent $6.51 billion on R&D, a 5.95 percent decrease from the $6.92 billion AbbVie spent on R&D in 2021
Furthermore, the modification and biosynthesis of these compounds or their formulations to achieve the requirements of clinical trials is also needed, and more attention should be given to these compounds in clinical trials so that they can be used to treat cancer patients and improve their clinical efficacy